These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7630125)

  • 1. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
    Sielaff TD; Hu MY; Rollins MD; Bloomer JR; Amiot B; Hu WS; Cerra FB
    Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved model of galactosamine-induced fulminant hepatic failure in the pig.
    Kalpana K; Ong HS; Soo KC; Tan SY; Prema Raj J
    J Surg Res; 1999 Apr; 82(2):121-30. PubMed ID: 10090819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver support effect of experimental extracorporeal bioartificial liver].
    Wang Y; Li M; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-galactosamine based canine acute liver failure model.
    Patzer JF; Block GD; Khanna A; Yin WY; Molmenti E; Gerber D; Kramer DJ; Scott VL; Aggarwal S; Wagner RA; Fulmer ML; Amiot BP; Mazariegos GV
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):354-67. PubMed ID: 14607707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
    Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J
    J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of a hollow fiber liver assist device.
    Jauregui HO; Mullon CJ; Trenkler D; Naik S; Santangini H; Press P; Muller TE; Solomon BA
    Hepatology; 1995 Feb; 21(2):460-9. PubMed ID: 7843721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines.
    Diaz-Buxo JA; Blumenthal S; Hayes D; Gores P; Gordon B
    Hepatology; 1997 Apr; 25(4):950-7. PubMed ID: 9096603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
    Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
    J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial hepatic support systems.
    Demetriou AA; Watanabe F; Rozga J
    Prog Liver Dis; 1995; 13():331-48. PubMed ID: 9224509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver.
    Hochleitner B; Hengster P; Bucher H; Ladurner R; Schneeberger S; Krismer A; Kleinsasser A; Barnas U; Klima G; Margreiter R
    Artif Organs; 2006 Dec; 30(12):906-14. PubMed ID: 17181831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of a porcine model of acute hepatic failure by intraportal injection of D-galactosamine and lipopolysaccharide].
    Peng CH; Xiao WD; Wu WD; Zhou GW; Zhang MJ; Shu M; Chen HX; Li HW
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1464-7. PubMed ID: 16061023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surgical model of fulminant hepatic failure in rabbits.
    Hung KC; Yong CC; Chen YS; Eng HL; Kuo FY; Lin CC; Young TH; Kobayashi E; Chen CL; Wang CC
    Liver Int; 2007 Dec; 27(10):1333-41. PubMed ID: 18036098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2].
    Guo JW; Xi D; Yan WM; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):691-4. PubMed ID: 19785959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a hybrid bio-artificial liver].
    Nagaki M; Muto Y
    Nihon Rinsho; 1994 Aug; 52(8):2205-13. PubMed ID: 7933612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane barrier of a porcine hepatocyte bioartificial liver.
    Nyberg SL; Yagi T; Matsushita T; Hardin J; Grande JP; Gibson LE; Platt JL
    Liver Transpl; 2003 Mar; 9(3):298-305. PubMed ID: 12619028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure.
    Detry O; Arkadopoulos N; Ting P; Kahaku E; Watanabe FD; Rozga J; Demetriou AA
    Am Surg; 1999 Oct; 65(10):934-8. PubMed ID: 10515538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.